Description

Future directions in regenerative medicine for alopecia, including gene therapy, biomaterial scaffolds, and 3D bioprinting of hair follicle structures.

Figure 10

Diagram

Source Paper

Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.

Pharmaceutics (2022)

PMID: 35335987

DOI: 10.3390/pharmaceutics14030612

Cite This Figure

![Figure 10: Future directions in regenerative medicine for alopecia, including gene therapy, biomaterial scaffolds, and 3D bioprinting of hair follicle structures.]()

> Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." *Pharmaceutics*, 2022. PMID: [35335987](https://pubmed.ncbi.nlm.nih.gov/35335987/)

<figure>
  <img src="" alt="Future directions in regenerative medicine for alopecia, including gene therapy, biomaterial scaffolds, and 3D bioprinting of hair follicle structures." />
  <figcaption>Figure 10. Future directions in regenerative medicine for alopecia, including gene therapy, biomaterial scaffolds, and 3D bioprinting of hair follicle structures.<br>  Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." <em>Pharmaceutics</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35335987/">35335987</a></figcaption>
</figure>

Preuves associées

Minoxidil pour Alopécie Androgénétique

Note A · 299 études

Finasteride pour Alopécie Androgénétique

Note A · 206 études

Thérapie PRP pour Alopecia Areata

Note A · 89 études

Minoxidil pour Alopecia Areata

Note A · 122 études

Thérapie PRP pour Alopécie Androgénétique

Note A · 144 études